Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 977 of 1,261

  1. US 7862605

    Coated implantable medical device

    Cook Regentec LLC · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  2. US 7862815

    Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  3. US 7863047

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  4. US 7863415

    Amino acid and peptide conjugates of amiloride and methods of use thereof

    The Regents of the University of California · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  5. US 7863041

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  6. US 2010331746

    METHOD OF USING ENOXAPARIN FOR REDUCING THE RISK OF DEATH IN ACUTELY ILL MEDICAL PATIENTS

    AVENTIS PHARMA SA [FR] · Granted Dec 30, 2010 · Expires Dec 25, 2030

    granted

  7. US 2010331426

    Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria

    AIR LIQUIDE SANTE INT [FR] · Granted Dec 30, 2010 · Expires Dec 25, 2030

    granted

  8. US 7858605

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  9. US 7858583

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  10. US 7858349

    Anti-cancer compounds

    The Regents of the University of Colorado · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  11. US 7858657

    Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  12. US 7858592

    Interfering RNAs against the promoter region of P53

    The Board of Regents of the University of Texas System · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  13. US 7858123

    Inorganic materials for hemostatic modulation and therapeutic wound healing

    The Regents of the University of California · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  14. US 7858795

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  15. US 7858790

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  16. US 7858786

    Pyrimidines and pyrazines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  17. US 7858749

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  18. US 7858635

    Spiro compounds as modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  19. US 7858633

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  20. US 7858797

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  21. US 7858792

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  22. WO 2010146171

    NOUVELLE MÉTHODE D'ADMINISTRATION D'UN ALLERGÈNE DANS UNE IMMUNOTHÉRAPIE ALLERGÈNE-SPÉCIFIQUE

    ALK ABELLO AS [DK] · Granted Dec 23, 2010 · Expires Dec 18, 2030

    granted

  23. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  24. US 7855191

    Agent having a destructive effect on malignant tumors and method for the production thereof

    C.Y.L. Pharmazeutika GmbH · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.